Guangzhou Improve Med Instrument (300030) — Tangible Net Worth Ratio
Guangzhou Improve Med Instrument (300030) has a Tangible Net Worth Ratio of 95.1% as of March 2026. This metric is calculated by deducting intangible assets (CN¥32.86 Million) from net assets (CN¥677.10 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset momentum of Guangzhou Improve Med Instrument to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Guangzhou Improve Med Instrument Tangible Net Worth Ratio (2006–2025)
This chart shows how Guangzhou Improve Med Instrument's Tangible Net Worth Ratio has changed across 20 annual periods from 2006 to 2025. As of March 2026, the ratio stands at 95.1%, reflecting net assets of CN¥677.10 Million with intangible assets of CN¥32.86 Million CNY. For live market cap and overall valuation, see 300030 market cap overview.
Annual Tangible Net Worth Ratio for Guangzhou Improve Med Instrument (2006–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Guangzhou Improve Med Instrument from 2006 to 2025, covering 20 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore 300030 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 94.9% | CN¥655.10 Million | CN¥33.71 Million | CN¥1.03 Billion | ▲ +0.9 pp |
| 2024 | 94.0% | CN¥643.86 Million | CN¥38.64 Million | CN¥1.24 Billion | ▼ -0.2 pp |
| 2023 | 94.2% | CN¥762.33 Million | CN¥44.29 Million | CN¥1.43 Billion | ▲ +3.5 pp |
| 2022 | 90.7% | CN¥820.61 Million | CN¥76.22 Million | CN¥1.56 Billion | ▲ +2.5 pp |
| 2021 | 88.2% | CN¥1.03 Billion | CN¥121.51 Million | CN¥1.83 Billion | ▲ +1.7 pp |
| 2020 | 86.5% | CN¥1.00 Billion | CN¥135.05 Million | CN¥1.74 Billion | ▲ +4.6 pp |
| 2019 | 81.9% | CN¥838.26 Million | CN¥151.58 Million | CN¥1.51 Billion | ▲ +0.7 pp |
| 2018 | 81.3% | CN¥815.47 Million | CN¥152.80 Million | CN¥1.51 Billion | ▼ -3.6 pp |
| 2017 | 84.9% | CN¥963.72 Million | CN¥145.64 Million | CN¥1.75 Billion | ▼ -3.7 pp |
| 2016 | 88.6% | CN¥954.18 Million | CN¥109.10 Million | CN¥1.47 Billion | ▼ -0.5 pp |
| 2015 | 89.0% | CN¥930.46 Million | CN¥102.15 Million | CN¥1.44 Billion | ▼ -1.3 pp |
| 2014 | 90.3% | CN¥782.00 Million | CN¥75.52 Million | CN¥1.02 Billion | ▼ -1.8 pp |
| 2013 | 92.1% | CN¥772.70 Million | CN¥60.68 Million | CN¥883.08 Million | ▼ -2.7 pp |
| 2012 | 94.8% | CN¥687.93 Million | CN¥35.62 Million | CN¥766.53 Million | ▼ -3.0 pp |
| 2011 | 97.8% | CN¥648.25 Million | CN¥14.01 Million | CN¥716.72 Million | ▼ -0.5 pp |
| 2010 | 98.3% | CN¥592.55 Million | CN¥9.83 Million | CN¥651.24 Million | ▼ 0.0 pp |
| 2009 | 98.4% | CN¥563.53 Million | CN¥9.17 Million | CN¥657.84 Million | ▲ +10.0 pp |
| 2008 | 88.4% | CN¥78.73 Million | CN¥9.12 Million | CN¥141.69 Million | ▼ -0.7 pp |
| 2007 | 89.1% | CN¥58.27 Million | CN¥6.33 Million | CN¥73.88 Million | ▼ -3.6 pp |
| 2006 | 92.8% | CN¥19.33 Million | CN¥1.40 Million | CN¥39.95 Million | — |